Ateco Pharma Egypt hosted a delegation from the US Embassy on December 14, 2024, to explore potential collaboration and export agreements. The delegation included notable figures such as Scott Bozell and Harry Kriz, who engaged with Ateco's leadership to discuss opportunities for partnership in the pharmaceutical sector. CEO Waheed Ateek emphasized the company's commitment to producing high-quality pharmaceutical products and highlighted their recent successes in exporting to South America in 2023. The delegation toured Ateco's facility located in Ain Sokhna, which commenced production in late 2022. This factory represents a significant investment of over EGP 1 billion and spans 20,000 square meters within the Suez Canal Economic Zone, showcasing Egypt's growing capabilities in the pharmaceutical industry. Looking ahead, Ateco Pharma aims to expand its production lines and introduce new products in 2025 and 2026, further solidifying its position in the market and enhancing its export potential [53d68363].